{
  "doc_id": "467783dd698afc87114c37f9873084c3b8b4d2191d85c1f2d81342f7bc79934d",
  "chunk_entities": [
    {
      "chunk_id": "e339c745ac84b867549bc7e2b312be83",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "Clinical Depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "Neurochemistry of Depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "Behavioral Model of Depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Antidepressants",
          "context": "e. Antidepressants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Alkaloid",
          "context": "Alkaloid Chemistry"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "The Mesembrine family"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Pharmacological Activity of Mesembrine"
        }
      ]
    },
    {
      "chunk_id": "080a3594175d8b1fae0285b0cb88cc3f",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "major depressive disorder",
          "context": "characterizes major depressive disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depressive episode",
          "context": "or a major depressive episode"
        },
        {
          "entity_type": "Effect",
          "entity_name": "depressed mood",
          "context": "having a depressed mood"
        },
        {
          "entity_type": "Effect",
          "entity_name": "feelings of worthlessness",
          "context": "including feelings of worthlessness"
        },
        {
          "entity_type": "Effect",
          "entity_name": "excessive guilt",
          "context": "or excessive guilt"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decreases in interest in pleasurable activities or relationships",
          "context": "decreases in interest in pleasurable activities or relationships"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anhedonia",
          "context": "(also called anhedonia)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "fatigue",
          "context": "anhedonia), fatigue"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impaired concentration",
          "context": "fatigue, impaired concentration"
        },
        {
          "entity_type": "Effect",
          "entity_name": "insomnia",
          "context": "concentration, insomnia"
        },
        {
          "entity_type": "Effect",
          "entity_name": "hypersomnia",
          "context": "insomnia or hypersomnia"
        },
        {
          "entity_type": "Effect",
          "entity_name": "significant weight loss",
          "context": "significant weight loss or gain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "significant weight gain",
          "context": "significant weight loss or gain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "aches and pains",
          "context": "aches and pains in various parts of the body"
        },
        {
          "entity_type": "Effect",
          "entity_name": "restlessness",
          "context": "body, restlessness"
        },
        {
          "entity_type": "Effect",
          "entity_name": "thoughts of death or suicide",
          "context": "and thoughts of death or suicide"
        },
        {
          "entity_type": "Effect",
          "entity_name": "irritability",
          "context": "such as irritability"
        },
        {
          "entity_type": "Disease",
          "entity_name": "drug or alcohol abuse",
          "context": "and drug or alcohol abuse"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety disorders",
          "context": "Many anxiety disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "post-traumatic stress disorder",
          "context": "such as post-traumatic stress disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "PTSD",
          "context": "(PTSD)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "panic disorder",
          "context": "PTSD), panic disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "social phobia",
          "context": "panic disorder, social phobia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "generalized anxiety disorder",
          "context": "and generalized anxiety disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "tend to coexist with depression"
        }
      ]
    },
    {
      "chunk_id": "d0f81e7962d80a18dc3b671009f80fea",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "Treatment of depression varies"
        },
        {
          "entity_type": "Disease",
          "entity_name": "disorder",
          "context": "severity of the disorder"
        },
        {
          "entity_type": "Compound",
          "entity_name": "antidepressants",
          "context": "medications such as antidepressants"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "afflicted with depression"
        }
      ]
    },
    {
      "chunk_id": "8b04cc10be5c0d3cf000ea42dd17cab9",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "The neurochemistry of depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "neurotransmitters",
          "context": "systems of neurotransmitters"
        },
        {
          "entity_type": "Compound",
          "entity_name": "corticotropin",
          "context": "involves the corticotropin-"
        }
      ]
    },
    {
      "chunk_id": "0c2bb05946b91d4886a7458a6c800988",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "CRF",
          "context": "releasing factor (CRF) system"
        },
        {
          "entity_type": "Disease",
          "entity_name": "stress",
          "context": "role in stress"
        },
        {
          "entity_type": "Compound",
          "entity_name": "peptide",
          "context": "CRF is a peptide"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ACTH",
          "context": "adrenocorticotropic hormone (ACTH)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glucocorticoids",
          "context": "secrete glucocorticoids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cortisol",
          "context": "primarily cortisol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CRH",
          "context": "CRH is produced"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depression",
          "context": "developing major depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "implicated in depression"
        }
      ]
    },
    {
      "chunk_id": "d31554bcc8ccef84e737e30d8b527c74",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "such as serotonin, dopamine, and norepinephrine."
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "such as serotonin, dopamine, and norepinephrine."
        },
        {
          "entity_type": "Compound",
          "entity_name": "norepinephrine",
          "context": "such as serotonin, dopamine, and norepinephrine."
        },
        {
          "entity_type": "Compound",
          "entity_name": "iproniazid",
          "context": "iproniazid, an antimycobacterial agent"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antimycobacterial",
          "context": "an antimycobacterial agent"
        },
        {
          "entity_type": "Disease",
          "entity_name": "tuberculosis",
          "context": "treatment for tuberculosis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "psychoactive",
          "context": "have psychoactive properties"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamines",
          "context": "neurotransmitters called monoamines."
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "class of antidepressants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine oxidase inhibitors",
          "context": "monoamine oxidase inhibitors, or MAOIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAOIs",
          "context": "monoamine oxidase inhibitors, or MAOIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine oxidase",
          "context": "The monoamine oxidase family of mitochondrial enzymes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine neurotransmitters",
          "context": "breakdown of monoamine neurotransmitters"
        },
        {
          "entity_type": "Compound",
          "entity_name": "isocarboxazid",
          "context": "MAOIs are isocarboxazid (Marplan)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phenelzine",
          "context": "and phenelzine (Nardil)."
        },
        {
          "entity_type": "Disease",
          "entity_name": "atypical depression",
          "context": "of atypical depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depressive disorder",
          "context": "with major depressive disorder"
        },
        {
          "entity_type": "Compound",
          "entity_name": "tyramine",
          "context": "substance called tyramine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "birth control pills",
          "context": "types of birth control pills"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cold and allergy medications",
          "context": "cold and allergy medications"
        },
        {
          "entity_type": "Compound",
          "entity_name": "herbal supplements",
          "context": "certain herbal supplements"
        },
        {
          "entity_type": "Compound",
          "entity_name": "prescription painkillers",
          "context": "and prescription painkillers."
        },
        {
          "entity_type": "Effect",
          "entity_name": "increases in blood pressure",
          "context": "drastic increases in blood pressure"
        }
      ]
    },
    {
      "chunk_id": "77106f40096a4abc78edae7a2a860b87",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "MAOIs",
          "context": "with MAOIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "selegiline",
          "context": "Emsam (selegiline)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "fewer side effects",
          "context": "causes fewer side effects"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low enough doses",
          "context": "with low enough doses"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low doses",
          "context": "low doses also only affect MAO-B"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO-B",
          "context": "affect MAO-B"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "interact significantly with SSRIs"
        },
        {
          "entity_type": "Disease",
          "entity_name": "serotonin syndrome",
          "context": "developing serotonin syndrome"
        },
        {
          "entity_type": "Disease",
          "entity_name": "hallucinations",
          "context": "include hallucinations"
        },
        {
          "entity_type": "Disease",
          "entity_name": "seizures",
          "context": "hallucinations, seizures"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased sweating",
          "context": "increased sweating"
        },
        {
          "entity_type": "Disease",
          "entity_name": "confusion",
          "context": "sweating, confusion"
        },
        {
          "entity_type": "Disease",
          "entity_name": "muscle stiffness",
          "context": "confusion, muscle stiffness"
        },
        {
          "entity_type": "Disease",
          "entity_name": "changes in blood pressure",
          "context": "dangerous changes in blood pressure"
        },
        {
          "entity_type": "Disease",
          "entity_name": "heart arrhythmia",
          "context": "blood pressure or heart arrhythmia"
        }
      ]
    },
    {
      "chunk_id": "7c13a9291532e56bc7632070a3fd6cf4",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "administered with paroxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRI",
          "context": "paroxetine, a very successful SSRI"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "all three doses",
          "context": "at all three doses of paroxetine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "the two higher doses",
          "context": "at the two higher doses"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "the highest dose",
          "context": "at the highest dose only"
        }
      ]
    },
    {
      "chunk_id": "92fbe71557068478d12b3f463789ae29",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "structure of mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "N-methyl-3a-(3',4'-dimethoxyphenyl)-6-oxo-cis-octahydroindole",
          "context": "found to be N-methyl-3a-(3',4'-dimethoxyphenyl)-6-oxo-cis-octahydroindole"
        },
        {
          "entity_type": "Compound",
          "entity_name": "(+/-)-mesembrine",
          "context": "synthesis of (+/-)-mesembrine"
        }
      ]
    },
    {
      "chunk_id": "43d624a5a2382dbd97932bd7e24a1632",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "Sceletium tortuosum's mechanism of action"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "serotonin (5-HT) transporter system"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "serotonin (5-HT) transporter system"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitor of the serotonin (5-HT) transporter system",
          "context": "identified as an inhibitor of the serotonin (5-HT) transporter system"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reuptake of serotonin",
          "context": "responsible for the reuptake of serotonin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4",
          "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of the phosphodiesterase-4 (PDE4) enzyme",
          "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT reuptake inhibitors",
          "context": "5-HT reuptake inhibitors, also called SSRIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "5-HT reuptake inhibitors, also called SSRIs"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "treatment of depression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of PDE4",
          "context": "combination of this property with the inhibition of PDE4"
        },
        {
          "entity_type": "Effect",
          "entity_name": "therapeutic value",
          "context": "have greater therapeutic value"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP",
          "context": "regulated by cyclic AMP (cAMP)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "regulated by cyclic AMP (cAMP)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibit second messenger systems regulated by cyclic AMP",
          "context": "PDE4 has been shown to inhibit second messenger systems regulated by cyclic AMP"
        },
        {
          "entity_type": "Effect",
          "entity_name": "promoting the metabolism of cAMP",
          "context": "promoting the metabolism of cAMP"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "antidepressant effects may also result"
        },
        {
          "entity_type": "Effect",
          "entity_name": "upregulating cAMP",
          "context": "result from upregulating cAMP"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant actions",
          "context": "antidepressant actions of SSRIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "mesembrine appears to have a similar or faster effect"
        },
        {
          "entity_type": "Effect",
          "entity_name": "up-regulation of cAMP",
          "context": "effect on the up-regulation of cAMP"
        }
      ]
    },
    {
      "chunk_id": "a88313df5159b29f4392ab91c4ed7f77",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "effects of Sceletium tortuosum"
        },
        {
          "entity_type": "Disease",
          "entity_name": "psychological stress",
          "context": "model of psychological stress"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "given an extract of the plant"
        },
        {
          "entity_type": "Effect",
          "entity_name": "restraint stress",
          "context": "exposed to repeated restraint stress"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "Sceletium tortuosum was administered"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low dose",
          "context": "administered at a low dose"
        }
      ]
    },
    {
      "chunk_id": "294837870e4e25758ba1f51a1ae67705",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "acute doses of Zembrin"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "extract of Sceletium tortuosum"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rice powder",
          "context": "Sceletium tortuosum on rice powder"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-related activities",
          "context": "observe anxiety-related activities"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "anxiety-related activities"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "one 25 mg dose",
          "context": "took one 25 mg dose of Zembrin"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduced",
          "context": "reaction to fearful facial expressions was reduced"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuation of the amygdala-hypothalamus coupling",
          "context": "attenuation of the amygdala-hypothalamus coupling"
        },
        {
          "entity_type": "Effect",
          "entity_name": "SRI capabilities",
          "context": "SRI capabilities"
        },
        {
          "entity_type": "Effect",
          "entity_name": "PDE4 action",
          "context": "PDE4 action"
        }
      ]
    },
    {
      "chunk_id": "2f80c31841f94d1ad5804f3cb4e90fa9",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium may have potential"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reducing depression",
          "context": "in reducing depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "reducing depression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "help anxiety",
          "context": "can help anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "help anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "associated with depression"
        }
      ]
    },
    {
      "chunk_id": "4ef32b48acfb1dec14216a8df79536f6",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "ether soluble alkaloids",
          "context": "ether soluble alkaloids used in the animal experiments"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "Two concentrations of the alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phenylmethylsiloxane",
          "context": "HP-5 5% phenylmethylsiloxane capillary column"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.94 mg/mL",
          "context": "0.94 mg/mL and 4.23 mg/mL were prepared"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "4.23 mg/mL",
          "context": "0.94 mg/mL and 4.23 mg/mL were prepared"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "20mg/mL",
          "context": "from the 20mg/mL stock solution"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 \u00b5L",
          "context": "1 \u00b5L splitless injection"
        }
      ]
    },
    {
      "chunk_id": "c1b896e9a34367c30f74d876cca0a0f7",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "isoflourane",
          "context": "euthanized using isoflourane"
        }
      ]
    },
    {
      "chunk_id": "ff4ee09521688d8a2cb190bca901cf2a",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "Dried milled Sceletium tortuosum"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "24.2631 g",
          "context": "Sceletium tortuosum, 24.2631 g"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "250 mL",
          "context": "stirred for 1 hour with 250 mL"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.25M",
          "context": "250 mL 0.25M aqueous sulfuric acid"
        },
        {
          "entity_type": "Compound",
          "entity_name": "sulfuric acid",
          "context": "0.25M aqueous sulfuric acid"
        }
      ]
    },
    {
      "chunk_id": "8bce5b89ee2ae0022a3e3d134af71112",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Celite",
          "context": "screened through Celite"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ammonium hydroxide",
          "context": "conc. ammonium hydroxide"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "10 mL",
          "context": "10 mL conc. ammonium hydroxide"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dichloromethane",
          "context": "200 mL dichloromethane (DCM)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "200 mL",
          "context": "200 mL dichloromethane"
        },
        {
          "entity_type": "Compound",
          "entity_name": "sodium sulfate",
          "context": "dried over anhydrous sodium sulfate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "crude alkaloid",
          "context": "0.6670 g of crude alkaloid"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.6670 g",
          "context": "0.6670 g of crude alkaloid"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ether",
          "context": "The ether insoluble alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "ether insoluble alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "mesembrine isolation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "crude alkaloid",
          "context": "The crude alkaloid (0.6670 g)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.6670 g",
          "context": "crude alkaloid (0.6670 g)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ethyl acetate",
          "context": "2 mL ethyl acetate (EtOAc)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2 mL",
          "context": "2 mL ethyl acetate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "diethyl ether",
          "context": "50 mL diethyl ether"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "50 mL",
          "context": "50 mL diethyl ether"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Celite",
          "context": "glass wool and Celite"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.1202 g",
          "context": "yellow liquid 1.1202 g"
        },
        {
          "entity_type": "Compound",
          "entity_name": "EtOAc",
          "context": "residual EtOAc"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "ether soluble alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydrochloride salts",
          "context": "respective hydrochloride salts"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ether",
          "context": "dissolving in 2 mL ether"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2 mL",
          "context": "dissolving in 2 mL ether"
        },
        {
          "entity_type": "Compound",
          "entity_name": "HCL",
          "context": "2M HCL in ether"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2.0 mL",
          "context": "2.0 mL 2M HCL"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2M",
          "context": "2M HCL in ether"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ether",
          "context": "2M HCL in ether"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ether",
          "context": "2 x 20 mL ether"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2 x 20 mL",
          "context": "2 x 20 mL ether"
        },
        {
          "entity_type": "Compound",
          "entity_name": "argon",
          "context": "filled with argon"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ether",
          "context": "ether soluble alkaloid hydrochloride salts"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloid hydrochloride salts",
          "context": "ether soluble alkaloid hydrochloride salts"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "103.5 mg",
          "context": "103.5 mg of ether soluble alkaloid hydrochloride salts"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.379%",
          "context": "Yield: 0.379% alkaloid/g plant material"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloid",
          "context": "0.379% alkaloid/g plant material"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "g",
          "context": "alkaloid/g plant material"
        }
      ]
    },
    {
      "chunk_id": "eeeeee814bbc537765c7f87dd756e00e",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "members of the mesembrine alkaloid family"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Mesembranol was the most abundant alkaloid"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "67.0%",
          "context": "Mesembranol was the most abundant alkaloid at 67.0%"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "the namesake mesembrine made up 9.2% of the sample"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "9.2%",
          "context": "mesembrine made up 9.2% of the sample"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "Mesembrenol made up 15.8% of the sample"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "15.8%",
          "context": "Mesembrenol made up 15.8% of the sample"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenone",
          "context": "mesembrenone made up the smallest percentage of the sample"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "8.0%",
          "context": "mesembrenone made up the smallest percentage of the sample at 8.0%"
        }
      ]
    },
    {
      "chunk_id": "68a5736fe7c5e03525cbfec8ba5c6482",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "The low dose mesembrine group"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low dose",
          "context": "The low dose mesembrine group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "The paroxetine and the high dose mesembrine groups"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "the high dose mesembrine groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "the high dose mesembrine groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "The saline group"
        }
      ]
    },
    {
      "chunk_id": "47494907f230865b8cffa88c9ad5fd1a",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Paroxetine",
          "context": "The x-axis shows four groups: Paroxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Low Dose Mesembrine, High Dose Mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Saline",
          "context": "and Saline."
        },
        {
          "entity_type": "Dosage",
          "entity_name": "Low Dose Mesembrine",
          "context": "Low Dose Mesembrine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "High Dose Mesembrine",
          "context": "High Dose Mesembrine"
        }
      ]
    },
    {
      "chunk_id": "8a8a7ba908cb3663c089d1ebc568f03d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Paroxetine",
          "context": "four groups of mice (Paroxetine, Low Alkaloid, High Alkaloid, Saline)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Alkaloid",
          "context": "Low Alkaloid, High Alkaloid"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Saline",
          "context": "four groups of mice (Paroxetine, Low Alkaloid, High Alkaloid, Saline)"
        }
      ]
    },
    {
      "chunk_id": "f7b6e625bd7e8a063f36e58ebab72f29",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "paroxetine exhibits its antidepressant effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "paroxetine exhibits its antidepressant effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "compared to the saline group"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "analog to depression in humans"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Paroxetine",
          "context": "Paroxetine is an antidepressant"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "Paroxetine is an antidepressant"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "dosages of mesembrine alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "paroxetine was effective at producing changes"
        }
      ]
    },
    {
      "chunk_id": "e6deb71aa2c4685ee0abf309380f5146",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloid",
          "context": "high dose mesembrine alkaloid group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "paroxetine group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "The saline group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloid",
          "context": "low dose mesembrine alkaloid group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "and the saline group"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "high dose mesembrine alkaloid group"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low dose",
          "context": "low dose mesembrine alkaloid group"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "producing antidepressant effects"
        }
      ]
    },
    {
      "chunk_id": "f6ad8f240a2d4a654cd1cd3b274579c2",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Paroxetine",
          "context": "Paroxetine works as a selective serotonin reuptake inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective serotonin reuptake inhibitor",
          "context": "works as a selective serotonin reuptake inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "some of the mesembrine alkaloids are thought to act"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "The alkaloids are also thought to act"
        },
        {
          "entity_type": "Effect",
          "entity_name": "phosphodiesterase-4 inhibitors",
          "context": "act as phosphodiesterase-4 inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "shown to have antidepressant effects"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low dose",
          "context": "the low dose of mesembrine alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "low dose of mesembrine alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "seen in paroxetine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "the high dose of mesembrine alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "high dose of mesembrine alkaloids"
        }
      ]
    },
    {
      "chunk_id": "c46a2819bddbcde9d1dc83c105e75a1e",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Locomotor activity",
          "context": "Locomotor activity was assessed"
        },
        {
          "entity_type": "Effect",
          "entity_name": "movement",
          "context": "effect on the mice's movement"
        },
        {
          "entity_type": "Effect",
          "entity_name": "exploratory behaviors",
          "context": "natural exploratory behaviors of rodents"
        },
        {
          "entity_type": "Effect",
          "entity_name": "locomotor ability",
          "context": "assess their baseline locomotor ability"
        },
        {
          "entity_type": "Effect",
          "entity_name": "motoric effects",
          "context": "motoric effects may have influenced"
        },
        {
          "entity_type": "Effect",
          "entity_name": "behavioral despair",
          "context": "influenced the behavioral despair results"
        },
        {
          "entity_type": "Effect",
          "entity_name": "locomotor ability",
          "context": "interfered with the locomotor ability"
        }
      ]
    },
    {
      "chunk_id": "407568d6cea91ccfd280063c8609081d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "hallmark of paroxetine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloid",
          "context": "low dose mesembrine alkaloid group"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mechanism of action",
          "context": "similar mechanism of action"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloid",
          "context": "high dose mesembrine alkaloid"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "saline groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "low dose mesembrine alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "paroxetine groups"
        },
        {
          "entity_type": "Effect",
          "entity_name": "locomotor scores",
          "context": "lower average locomotor scores"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "paroxetine and the low dose mesembrine alkaloid groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloid",
          "context": "low dose mesembrine alkaloid groups"
        },
        {
          "entity_type": "Effect",
          "entity_name": "locomotor activity",
          "context": "increase the locomotor activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "compared to the saline group"
        },
        {
          "entity_type": "Effect",
          "entity_name": "locomotor interference",
          "context": "produced any kind of locomotor interference"
        }
      ]
    },
    {
      "chunk_id": "a8357c2a98bf27104498f9238a9d8d30",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "paroxetine",
          "context": "seen in the paroxetine and low dose mesembrine alkaloid groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloid",
          "context": "low dose mesembrine alkaloid groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "saline",
          "context": "saline groups"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increase in locomotion",
          "context": "see if the increase in locomotion at the third time point"
        },
        {
          "entity_type": "Effect",
          "entity_name": "locomotion",
          "context": "stay at the same level of locomotion"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increase locomotion",
          "context": "paroxetine should increase locomotion"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "low dose",
          "context": "low dose mesembrine alkaloid groups"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "high dose mesembrine alkaloid"
        }
      ]
    },
    {
      "chunk_id": "c7fabd299c1d3fa293c8a29868f7b6a7",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Mesembrine is an inhibitor of PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "inhibitor of PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "relationship of rolipram"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "St. john's wort and depression"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Hypericum perforatum",
          "context": "St. john's wort and depression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressants",
          "context": "Antidepressants. Retrieved October 2013"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "What is depression?"
        },
        {
          "entity_type": "Compound",
          "entity_name": "metabolites",
          "context": "their metabolites"
        },
        {
          "entity_type": "Plant",
          "entity_name": "south african plants",
          "context": "south african plants used as remedies"
        },
        {
          "entity_type": "Effect",
          "entity_name": "remedies",
          "context": "plants used as remedies"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SAM-e",
          "context": "SAM-e may ease depression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "ease depression",
          "context": "SAM-e may ease depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "SAM-e may ease depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phytochemical content",
          "context": "phytochemical content of sceletiu tortuosum"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "phytochemical content of sceletiu tortuosum"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "preparation of \"kougoed\""
        },
        {
          "entity_type": "Plant",
          "entity_name": "plant material",
          "context": "fermentation of plant material"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "The mesembrine alkaloids"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant treatments",
          "context": "sensitive to antidepressant treatments"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "Depression: A new animal model"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant behavioral effects",
          "context": "Antidepressant behavioral effects by dual inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of monoamine reuptake",
          "context": "dual inhibition of monoamine reuptake"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "inhibition of monoamine reuptake"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "Global depression statistics"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pharmacologically active",
          "context": "quantification of pharmacologically active alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "pharmacologically active alkaloids in sceletium tortuosum"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "alkaloids in sceletium tortuosum raw material"
        }
      ]
    }
  ],
  "total_entities": 293,
  "extraction_date": "2026-02-01T08:37:09.714968+00:00"
}